IBDEI3F8 ; ; 19-NOV-2015
;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,57550,0)
;;=D68.318^^267^2880^16
;;^UTILITY(U,$J,358.3,57550,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57550,1,3,0)
;;=3^Hemorrhagic Disorder d/t Intrns Circ Anticoag,Antib,Inhib
;;^UTILITY(U,$J,358.3,57550,1,4,0)
;;=4^D68.318
;;^UTILITY(U,$J,358.3,57550,2)
;;=^340504
;;^UTILITY(U,$J,358.3,57551,0)
;;=R50.9^^267^2880^15
;;^UTILITY(U,$J,358.3,57551,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57551,1,3,0)
;;=3^Fever,Unspec
;;^UTILITY(U,$J,358.3,57551,1,4,0)
;;=4^R50.9
;;^UTILITY(U,$J,358.3,57551,2)
;;=^5019512
;;^UTILITY(U,$J,358.3,57552,0)
;;=R53.81^^267^2880^22
;;^UTILITY(U,$J,358.3,57552,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57552,1,3,0)
;;=3^Malaise
;;^UTILITY(U,$J,358.3,57552,1,4,0)
;;=4^R53.81
;;^UTILITY(U,$J,358.3,57552,2)
;;=^5019518
;;^UTILITY(U,$J,358.3,57553,0)
;;=R53.83^^267^2880^14
;;^UTILITY(U,$J,358.3,57553,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57553,1,3,0)
;;=3^Fatigue
;;^UTILITY(U,$J,358.3,57553,1,4,0)
;;=4^R53.83
;;^UTILITY(U,$J,358.3,57553,2)
;;=^5019520
;;^UTILITY(U,$J,358.3,57554,0)
;;=R60.0^^267^2880^12
;;^UTILITY(U,$J,358.3,57554,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57554,1,3,0)
;;=3^Edema,Localized
;;^UTILITY(U,$J,358.3,57554,1,4,0)
;;=4^R60.0
;;^UTILITY(U,$J,358.3,57554,2)
;;=^5019532
;;^UTILITY(U,$J,358.3,57555,0)
;;=R60.1^^267^2880^11
;;^UTILITY(U,$J,358.3,57555,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57555,1,3,0)
;;=3^Edema,Generalized
;;^UTILITY(U,$J,358.3,57555,1,4,0)
;;=4^R60.1
;;^UTILITY(U,$J,358.3,57555,2)
;;=^5019533
;;^UTILITY(U,$J,358.3,57556,0)
;;=R60.9^^267^2880^13
;;^UTILITY(U,$J,358.3,57556,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57556,1,3,0)
;;=3^Edema,Unspec
;;^UTILITY(U,$J,358.3,57556,1,4,0)
;;=4^R60.9
;;^UTILITY(U,$J,358.3,57556,2)
;;=^5019534
;;^UTILITY(U,$J,358.3,57557,0)
;;=R63.4^^267^2880^1
;;^UTILITY(U,$J,358.3,57557,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57557,1,3,0)
;;=3^Abnormal Weight Loss
;;^UTILITY(U,$J,358.3,57557,1,4,0)
;;=4^R63.4
;;^UTILITY(U,$J,358.3,57557,2)
;;=^5019542
;;^UTILITY(U,$J,358.3,57558,0)
;;=Z79.4^^267^2880^21
;;^UTILITY(U,$J,358.3,57558,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57558,1,3,0)
;;=3^Long Term Use of Insulin,Current
;;^UTILITY(U,$J,358.3,57558,1,4,0)
;;=4^Z79.4
;;^UTILITY(U,$J,358.3,57558,2)
;;=^5063334
;;^UTILITY(U,$J,358.3,57559,0)
;;=Z79.01^^267^2880^20
;;^UTILITY(U,$J,358.3,57559,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57559,1,3,0)
;;=3^Long Term Use of Anticoagulants,Current
;;^UTILITY(U,$J,358.3,57559,1,4,0)
;;=4^Z79.01
;;^UTILITY(U,$J,358.3,57559,2)
;;=^5063330
;;^UTILITY(U,$J,358.3,57560,0)
;;=E10.649^^267^2880^5
;;^UTILITY(U,$J,358.3,57560,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57560,1,3,0)
;;=3^Diabetes Type 1 w/ Hypoglycemia
;;^UTILITY(U,$J,358.3,57560,1,4,0)
;;=4^E10.649
;;^UTILITY(U,$J,358.3,57560,2)
;;=^5002622
;;^UTILITY(U,$J,358.3,57561,0)
;;=E11.649^^267^2880^9
;;^UTILITY(U,$J,358.3,57561,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57561,1,3,0)
;;=3^Diabetes Type 2 w/ Hypoglycemia
;;^UTILITY(U,$J,358.3,57561,1,4,0)
;;=4^E11.649
;;^UTILITY(U,$J,358.3,57561,2)
;;=^5002662
;;^UTILITY(U,$J,358.3,57562,0)
;;=E66.1^^267^2880^23
;;^UTILITY(U,$J,358.3,57562,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57562,1,3,0)
;;=3^Morbid Obesity d/t Drugs
;;^UTILITY(U,$J,358.3,57562,1,4,0)
;;=4^E66.1
;;^UTILITY(U,$J,358.3,57562,2)
;;=^5002828
;;^UTILITY(U,$J,358.3,57563,0)
;;=E66.2^^267^2880^25
;;^UTILITY(U,$J,358.3,57563,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI3F8 3973 printed Apr 09, 2024@21:33:33 Page 2
IBDEI3F8 ; ; 19-NOV-2015
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,99)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,57550,0)
+2 ;;=D68.318^^267^2880^16
+3 ;;^UTILITY(U,$J,358.3,57550,1,0)
+4 ;;=^358.31IA^4^2
+5 ;;^UTILITY(U,$J,358.3,57550,1,3,0)
+6 ;;=3^Hemorrhagic Disorder d/t Intrns Circ Anticoag,Antib,Inhib
+7 ;;^UTILITY(U,$J,358.3,57550,1,4,0)
+8 ;;=4^D68.318
+9 ;;^UTILITY(U,$J,358.3,57550,2)
+10 ;;=^340504
+11 ;;^UTILITY(U,$J,358.3,57551,0)
+12 ;;=R50.9^^267^2880^15
+13 ;;^UTILITY(U,$J,358.3,57551,1,0)
+14 ;;=^358.31IA^4^2
+15 ;;^UTILITY(U,$J,358.3,57551,1,3,0)
+16 ;;=3^Fever,Unspec
+17 ;;^UTILITY(U,$J,358.3,57551,1,4,0)
+18 ;;=4^R50.9
+19 ;;^UTILITY(U,$J,358.3,57551,2)
+20 ;;=^5019512
+21 ;;^UTILITY(U,$J,358.3,57552,0)
+22 ;;=R53.81^^267^2880^22
+23 ;;^UTILITY(U,$J,358.3,57552,1,0)
+24 ;;=^358.31IA^4^2
+25 ;;^UTILITY(U,$J,358.3,57552,1,3,0)
+26 ;;=3^Malaise
+27 ;;^UTILITY(U,$J,358.3,57552,1,4,0)
+28 ;;=4^R53.81
+29 ;;^UTILITY(U,$J,358.3,57552,2)
+30 ;;=^5019518
+31 ;;^UTILITY(U,$J,358.3,57553,0)
+32 ;;=R53.83^^267^2880^14
+33 ;;^UTILITY(U,$J,358.3,57553,1,0)
+34 ;;=^358.31IA^4^2
+35 ;;^UTILITY(U,$J,358.3,57553,1,3,0)
+36 ;;=3^Fatigue
+37 ;;^UTILITY(U,$J,358.3,57553,1,4,0)
+38 ;;=4^R53.83
+39 ;;^UTILITY(U,$J,358.3,57553,2)
+40 ;;=^5019520
+41 ;;^UTILITY(U,$J,358.3,57554,0)
+42 ;;=R60.0^^267^2880^12
+43 ;;^UTILITY(U,$J,358.3,57554,1,0)
+44 ;;=^358.31IA^4^2
+45 ;;^UTILITY(U,$J,358.3,57554,1,3,0)
+46 ;;=3^Edema,Localized
+47 ;;^UTILITY(U,$J,358.3,57554,1,4,0)
+48 ;;=4^R60.0
+49 ;;^UTILITY(U,$J,358.3,57554,2)
+50 ;;=^5019532
+51 ;;^UTILITY(U,$J,358.3,57555,0)
+52 ;;=R60.1^^267^2880^11
+53 ;;^UTILITY(U,$J,358.3,57555,1,0)
+54 ;;=^358.31IA^4^2
+55 ;;^UTILITY(U,$J,358.3,57555,1,3,0)
+56 ;;=3^Edema,Generalized
+57 ;;^UTILITY(U,$J,358.3,57555,1,4,0)
+58 ;;=4^R60.1
+59 ;;^UTILITY(U,$J,358.3,57555,2)
+60 ;;=^5019533
+61 ;;^UTILITY(U,$J,358.3,57556,0)
+62 ;;=R60.9^^267^2880^13
+63 ;;^UTILITY(U,$J,358.3,57556,1,0)
+64 ;;=^358.31IA^4^2
+65 ;;^UTILITY(U,$J,358.3,57556,1,3,0)
+66 ;;=3^Edema,Unspec
+67 ;;^UTILITY(U,$J,358.3,57556,1,4,0)
+68 ;;=4^R60.9
+69 ;;^UTILITY(U,$J,358.3,57556,2)
+70 ;;=^5019534
+71 ;;^UTILITY(U,$J,358.3,57557,0)
+72 ;;=R63.4^^267^2880^1
+73 ;;^UTILITY(U,$J,358.3,57557,1,0)
+74 ;;=^358.31IA^4^2
+75 ;;^UTILITY(U,$J,358.3,57557,1,3,0)
+76 ;;=3^Abnormal Weight Loss
+77 ;;^UTILITY(U,$J,358.3,57557,1,4,0)
+78 ;;=4^R63.4
+79 ;;^UTILITY(U,$J,358.3,57557,2)
+80 ;;=^5019542
+81 ;;^UTILITY(U,$J,358.3,57558,0)
+82 ;;=Z79.4^^267^2880^21
+83 ;;^UTILITY(U,$J,358.3,57558,1,0)
+84 ;;=^358.31IA^4^2
+85 ;;^UTILITY(U,$J,358.3,57558,1,3,0)
+86 ;;=3^Long Term Use of Insulin,Current
+87 ;;^UTILITY(U,$J,358.3,57558,1,4,0)
+88 ;;=4^Z79.4
+89 ;;^UTILITY(U,$J,358.3,57558,2)
+90 ;;=^5063334
+91 ;;^UTILITY(U,$J,358.3,57559,0)
+92 ;;=Z79.01^^267^2880^20
+93 ;;^UTILITY(U,$J,358.3,57559,1,0)
+94 ;;=^358.31IA^4^2
+95 ;;^UTILITY(U,$J,358.3,57559,1,3,0)
+96 ;;=3^Long Term Use of Anticoagulants,Current
+97 ;;^UTILITY(U,$J,358.3,57559,1,4,0)
+98 ;;=4^Z79.01
+99 ;;^UTILITY(U,$J,358.3,57559,2)
+100 ;;=^5063330
+101 ;;^UTILITY(U,$J,358.3,57560,0)
+102 ;;=E10.649^^267^2880^5
+103 ;;^UTILITY(U,$J,358.3,57560,1,0)
+104 ;;=^358.31IA^4^2
+105 ;;^UTILITY(U,$J,358.3,57560,1,3,0)
+106 ;;=3^Diabetes Type 1 w/ Hypoglycemia
+107 ;;^UTILITY(U,$J,358.3,57560,1,4,0)
+108 ;;=4^E10.649
+109 ;;^UTILITY(U,$J,358.3,57560,2)
+110 ;;=^5002622
+111 ;;^UTILITY(U,$J,358.3,57561,0)
+112 ;;=E11.649^^267^2880^9
+113 ;;^UTILITY(U,$J,358.3,57561,1,0)
+114 ;;=^358.31IA^4^2
+115 ;;^UTILITY(U,$J,358.3,57561,1,3,0)
+116 ;;=3^Diabetes Type 2 w/ Hypoglycemia
+117 ;;^UTILITY(U,$J,358.3,57561,1,4,0)
+118 ;;=4^E11.649
+119 ;;^UTILITY(U,$J,358.3,57561,2)
+120 ;;=^5002662
+121 ;;^UTILITY(U,$J,358.3,57562,0)
+122 ;;=E66.1^^267^2880^23
+123 ;;^UTILITY(U,$J,358.3,57562,1,0)
+124 ;;=^358.31IA^4^2
+125 ;;^UTILITY(U,$J,358.3,57562,1,3,0)
+126 ;;=3^Morbid Obesity d/t Drugs
+127 ;;^UTILITY(U,$J,358.3,57562,1,4,0)
+128 ;;=4^E66.1
+129 ;;^UTILITY(U,$J,358.3,57562,2)
+130 ;;=^5002828
+131 ;;^UTILITY(U,$J,358.3,57563,0)
+132 ;;=E66.2^^267^2880^25
+133 ;;^UTILITY(U,$J,358.3,57563,1,0)
+134 ;;=^358.31IA^4^2
